GLGa Hye Lee

Ga Hye Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ga Hye Lee has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Won-Woo Lee

    Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Republic of Korea

    4 shared publications
  • Bonah Kim

    BK21Plus Biomedical Science Project, Seoul National University College of Medicine, Seoul, South Korea

    1 shared publication
  • Chan Joo Lee

    Department of Health Promotion and Disease Prevention, Severance Hospital, Seoul, South Korea

    1 shared publication
  • Eun Bong Lee

    Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

    1 shared publication
  • Eun Young Lee

    Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

    1 shared publication
  • Hee Tae Yu

    Division of Cardiology, Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea

    1 shared publication

Latest Publications

  • Open Access

    Immunosenescent characteristics of T cells in young patients following haploidentical haematopoietic stem cell transplantation from parental donors

    by Ga Hye Lee, Kyung Taek Hong, Jung Yoon Choi, Hee Young Shin, Won‐Woo Lee, Hyoung Jin Kang

    Objectives: Paediatric and adolescent patients in need of allogeneic haematopoietic stem cell transplantation (HSCT) generally receive stem cells from older, unrelated or parental donors when a sibling donor is not available. Despite encouraging clinical outcomes, it has been suggested that immune reconstitution accompanied by increased replicative stress and a large difference between donor and recipient age may worsen immunosenescence in paediatric recipients.Methods: In this study, paired samples were collected at the same time from donors and recipients of haploidentical haematopoietic stem cell transplantation (HaploSCT). We then conducted flow cytometry‐based phenotypic and functional analyses and telomere length (TL) measurements of 21 paired T‐cell sets from parental donors and children who received T‐cell‐replete HaploSCT with post‐transplant cyclophosphamide (PTCy).Results: Senescent T cells, CD28− or CD57+ cells, were significantly expanded in patients. Further, not only CD4+CD28− T cells, but also CD4+CD28+ T cells showed reduced cytokine production capacity and impaired polyfunctionality compared with parental donors, whereas their TCR‐mediated proliferation capacity was comparable. Of note, the TL in patient T cells was preserved, or even slightly longer, in senescent T cells compared with donor cells. Regression analysis showed that senescent features of CD4+ and CD8+ T cells in patients were influenced by donor age and the frequency of CD28− cells, respectively.Conclusion: Our data suggest that in paediatric HaploSCT, premature immunosenescent changes occur in T cells from parental donors, and therefore, long‐term immune monitoring should be conducted.


  • Open Access

    Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)

    by Hee Young Kim, Tae-Hyun Yoo, Yuri Hwang, Ga Hye Lee, Bonah Kim, Jiyeon Jang, Hee Tae Yu, Min Chang Kim, Joo-Youn Cho, Chan Joo Lee, et al.

    Progressive renal failure causes uremia-related immune dysfunction, which features a chronic inflammatory milieu. Given the central role of end-stage renal disease (ESRD)-related immune dysfunction in the pathogenesis of cardiovascular diseases (CVDs), much attention has been focused on how uremic toxins affect cellular immunity and the mechanisms underlying pathogenesis of atherosclerosis in ESRD patients. Here, we investigated the characteristics of monocytes and CD4+ T cells in ESRD patients and the immune responses induced by indoxyl sulfate (IS), a key uremic toxin, in order to explore the pathogenic effects of these cells on vascular endothelial cells. In ESRD patients, monocytes respond to IS through the aryl hydrocarbon receptor (AhR) and consequently produce increased levels of TNF-α. Upon stimulation with TNF-α, human vascular endothelial cells produce copious amounts of CX3CL1, a chemokine ligand of CX3CR1 that is highly expressed on CD4+CD28−T cells, the predominantly expanded cell type in ESRD patients. A migration assay showed that CD4+CD28− T cells were preferentially recruited by CX3CL1. Moreover, activated CD4+CD28− T cells exhibited cytotoxic capability allowing for the induction of apoptosis in HUVECs. Our findings suggest that in ESRD, IS-mediated immune dysfunction may cause vascular endothelial cell damage and thus, this toxin plays a pivotal role in the pathogenesis of CVD.


  • Open Access

    Elderly Patients Exhibit Stronger Inflammatory Responses during Gout Attacks

    by Jae Hyun Lee, Ji Ae Yang, Kichul Shin, Ga Hye Lee, Won Woo Lee, Eun Young Lee, Yeong Wook Song, Eun Bong Lee, Jin Kyun Park

    Lee JH, et al. J Korean Med Sci. 2017 Dec;32(12):1967-1973. https://doi.org/10.3346/jkms.2017.32.12.1967


  • Open Access

    Unusual CD4+CD28−T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders

    by Ga Hye Lee, Won-Woo Lee

    Lee GH, et al. Immune Netw. 2016 Dec;16(6):322-329. https://doi.org/10.4110/in.2016.16.6.322